Sanofi Consumer Healthcare India Ltd vs Zenith Drugs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Sanofi Consumer Healthcare India Ltd is ₹ 4802 as of 18 May 15:30 . The P/E Ratio of Sanofi Consumer Healthcare India Ltd is 0 as of March 2022 .The P/E Ratio of Zenith Drugs Ltd is 0 as of March 2022 . The Market Cap of Sanofi Consumer Healthcare India Ltd is ₹ 0 crore as of March 2022 .The Market Cap of Zenith Drugs Ltd is ₹ 0 crore as of March 2022 . The revenue of Sanofi Consumer Healthcare India Ltd for the Jun '26 is ₹ 234.8 crore as compare to the Dec '25 revenue of ₹ 255.6 crore. This represent the decline of -8.14% The revenue of Zenith Drugs Ltd for the Jun '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Sanofi Consumer Healthcare India Ltd for the Jun '26 is ₹ 94.4 crore as compare to the Dec '25 ebitda of ₹ 94.4 crore. This represent the decline of 0% The ebitda of Zenith Drugs Ltd for the Jun '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Sanofi Consumer Healthcare India Ltd changed from ₹ 62.7 crore to ₹ 67.8 crore over 7 quarters. This represents a CAGR of 4.57% The net profit of Zenith Drugs Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The dividend payout of Sanofi Consumer Healthcare India Ltd changed from 6.06 % to 0 % over 7 quarters. This represents a CAGR of -100.00% The dividend payout of Zenith Drugs Ltd changed from 8.99 % to 0 % over 2 quarters. This represents a CAGR of -100.00% .

About Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi's global strategy to establish a standalone Consumer Healthcare business.
This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity.
The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024.

About Zenith Drugs Ltd

Zenith Drugs Limited was originally incorporated on November 15, 2000 as a Private Limited Company as 'Zenith Drugs Private Limited' issued by the Registrar of Companies, in the State of Madhya Pradesh, Gwalior.
Subsequently, Company was converted into Public Limited and consequently, the name of the Company was changed to Zenith Drugs Limited' pursuance to issuance of a Fresh Certificate of Incorporation on September 13, 2023 by the Registrar of Companies, Gwalior. Zenith are a reputable pharmaceutical manufacturing and trading unit based out from Indore.
Zenith's core business centers on production of high-quality, cost-effective pharmaceutical formulations such as: ORS Powder; Liquid Orals; Oinments; Liquid Externals and Capsules.
With a diverse portfolio of formulations, the Company is specialized in manufacturing affordable and high quality medicines to meet the needs of patients.

FAQs for the comparison of Sanofi Consumer Healthcare India Ltd and Zenith Drugs Ltd

Which company has a larger market capitalization, Sanofi Consumer Healthcare India Ltd or Zenith Drugs Ltd?

Market cap of Sanofi Consumer Healthcare India Ltd is 11,059 Cr while Market cap of Zenith Drugs Ltd is 77 Cr

What are the key factors driving the stock performance of Sanofi Consumer Healthcare India Ltd and Zenith Drugs Ltd?

The stock performance of Sanofi Consumer Healthcare India Ltd and Zenith Drugs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sanofi Consumer Healthcare India Ltd and Zenith Drugs Ltd?

As of May 18, 2026, the Sanofi Consumer Healthcare India Ltd stock price is INR ₹4802.25. On the other hand, Zenith Drugs Ltd stock price is INR ₹45.35.

How do dividend payouts of Sanofi Consumer Healthcare India Ltd and Zenith Drugs Ltd compare?

To compare the dividend payouts of Sanofi Consumer Healthcare India Ltd and Zenith Drugs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.